Young‐Sam Keum

6.0k citations
59 papers · 5.1k indexed · 2 hit papers · h-index 28

Impact in

Papers in

Young‐Sam Keum

57 papers receiving 4.9k citations

Hit Papers

Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13 2012 · 330 citations
33020012026200920174008001.2k

Peers

Young‐Sam Keum
Comparison fields: 5 of 129
  • Biochemistry 532
  • Molecular Medicine 430
  • Pharmacology 741
  • Toxicology 210
  • Molecular Biology 3.2k
Replace Tin Oo Khor with:
Tin Oo Khor United States
Kyung‐Soo Chun South Korea
Hye‐Kyung Na South Korea
Ching‐Shu Lai Taiwan
Chi‐Cheng Lu Taiwan
Seong‐Su Han United States
Kasi Pandima Devi India
Dong‐Oh Moon South Korea
Bonglee Kim South Korea
De‐Xing Hou Japan
Young‐Sam Keum relative to Tin Oo Khor United States Tin Oo Khor's profile →
Citations per field
00.5×1.5×
Tin Oo Khor · 1×
Citations per year

Countries citing papers authored by Young‐Sam Keum

Since Specialization
Citations

This map shows the geographic impact of Young‐Sam Keum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Young‐Sam Keum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Young‐Sam Keum more than expected).

Fields of papers citing papers by Young‐Sam Keum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Young‐Sam Keum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Young‐Sam Keum. The network helps show where Young‐Sam Keum may publish in the future.

Co-authors

The 25 scholars most cited alongside Young‐Sam Keum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Young‐Sam Keum Line = papers co-authored together Young‐Sam Keum links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20236
3 20228
4 20228
5 20218
6 20207
7 202027
8 20208
9 201821
10 201825
11
Skin Protective Effect of Methylated Marliolide through Induction of NRF2/ARE
20181
12 201688
13 201610
14 201341
15 201268
16 2005113
17 2004232
18 2003138
19
Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation
Hit paper breakdown →
20011422
20 200093

About Young‐Sam Keum

Young‐Sam Keum is a scholar working on Toxicology, Molecular Medicine, Molecular Biology, Biochemistry and Applied Microbiology and Biotechnology, having authored 59 papers that have together received 5.1k indexed citations. Recurring topics across this work include Genomics, phytochemicals, and oxidative stress (34 papers), Glutathione Transferases and Polymorphisms (15 papers), Bioactive Compounds and Antitumor Agents (5 papers), Curcumin's Biomedical Applications (5 papers), Garlic and Onion Studies (4 papers), Heme Oxygenase-1 and Carbon Monoxide (4 papers), Ginseng Biological Effects and Applications (3 papers) and Natural product bioactivities and synthesis (3 papers). The work is most often cited by research in Biochemistry (532 citations), Molecular Medicine (430 citations), Pharmacology (741 citations), Toxicology (210 citations) and Molecular Biology (3.2k citations). Young‐Sam Keum has collaborated with scholars based in South Korea, United States and Germany. Frequent co-authors include Young‐Joon Surh, Seong‐Su Han, Kyung‐Soo Chun, Kwang-Kyun Park, Sang Sup Lee, Ah‐Ng Tony Kong, Bu Young Choi, Woo‐Sik Jeong, Jung Hwan Kim and Changjiang Xu. Their work appears in journals such as Antioxidants, Mutation research. Fundamental and molecular mechanisms of mutagenesis, Bioorganic & Medicinal Chemistry Letters, Free Radical Research and Biomolecules & Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026